肾移植术后1年代谢性酸中毒与心血管事件及死亡:观察性队列研究
该单中心观察性队列纳入2128例肾移植术后13.5个月内无心血管事件的受者,评估术后1年血清tCO2水平与后续心血管事件及全因死亡的关系。中位随访4.0年,tCO2<20 mEq/L与心血管事件风险增加独立相关(aHR 2.00),且主要归因于缺血性事件;tCO2<20 mEq/L也与全因死亡风险增加独立相关(aHR 1.43)。
要点
- 肾移植术后1年tCO2<20 mEq/L与心血管事件风险增加独立相关。
- 该关联主要归因于缺血性心血管事件,风险增加更显著。
- tCO2<20 mEq/L也与全因死亡风险增加独立相关。
核心结论
- 代谢性酸中毒是肾移植术后缺血性心血管事件的独立危险因素。
- 纠正酸中毒能否改善结局尚不明确。
研究设计与样本
- 单中心观察性队列研究,纳入2128例肾移植术后13.5个月内无心血管事件的受者。
- 暴露为移植术后1年时血清tCO2水平,结局为缺血性、心律失常性、心力衰竭性心血管事件及全因死亡。
- 采用多变量比例风险回归模型评估独立关联,限制性立方样条泊松模型探索非线性关联,线性样条比例风险模型评估不同tCO2水平的关联。
主要发现
- 代谢性酸中毒(tCO2<24 mEq/L)患病率为38.8%(n=826)。
- 中位随访4.0年期间,共发生384例心血管事件和610例死亡;心血管事件包括241例缺血性、137例心律失常性和150例心力衰竭事件。
- 与tCO2 24.0-25.9 mEq/L参考组相比,tCO2<20 mEq/L与心血管事件风险增加相关(aHR 2.00;95%CI 1.29-3.10),主要归因于缺血性心血管事件(aHR 2.28;95%CI 1.34-3.90)。
- 在tCO2<24 mEq/L者中,tCO2每降低1 mEq/L,所有心血管事件和缺血性事件风险分别增加17%和15%(所有心血管事件aHR 0.83;95%CI 0.74-0.94;缺血性心血管事件aHR 0.85;95%CI 0.74-0.99)。
- 与tCO2 24.0-25.9 mEq/L参考组相比,tCO2<20 mEq/L与全因死亡独立相关(aHR 1.43;95%CI 1.02-2.02);在tCO2<24 mEq/L者中,tCO2每降低1 mEq/L,死亡风险增加17%(aHR 0.83;95%CI 0.75-0.92)。
临床怎么用
- 肾移植术后应关注血清tCO2水平,识别代谢性酸中毒患者。
- 对tCO2<20 mEq/L的肾移植受者,应加强心血管风险评估与监测。
- 纠正酸中毒能否改善心血管结局尚无证据,需个体化决策。
局限性
- 单中心观察性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Recent studies suggest that metabolic acidosis is associated with mortality and graft failure in kidney transplant recipients. However, it is unknown whether serum bicarbonate (measured as total carbon dioxide [tCO2] in serum) levels predict cardiovascular events (CVEs) following kidney transplantation. STUDY DESIGN: Observational cohort study. SETTINGS & PARTICIPANTS: Single-center study of 2,128 kidney transplant recipients free of CVEs during the first 13.5 months following transplantation. PREDICTOR: tCO2 level at 1 year posttransplantation. OUTCOMES: Ischemic, arrhythmic, and heart failure CVEs and death from any cause. ANALYTICAL APPROACH: Independent associations were assessed using multivariable proportional hazards regression models. Restricted cubic spline Poisson models were used to explore nonlinear associations. Linear spline proportional hazards models were used to assess associations at different tCO2 levels. RESULTS: The prevalence of metabolic acidosis defined as tCO2 level < 24 mEq/L was 38.8% (n=826). There were 384 recipients with a CVE and 610 deaths during a median follow-up of 4.0 years. CVEs included 241 ischemic, 137 arrhythmic, and 150 heart failure events. tCO2 level < 20 mEq/L was associated with increased risk for CVEs (adjusted HR [aHR], 2.00; 95% CI, 1.29-3.10) compared to the reference category of tCO2 level of 24.0 to 25.9 mEq/L. This association was primarily due to ischemic CVEs (aHR, 2.28; 95% CI, 1.34-3.90). For every 1 mEq/L lower tCO2 level for those with tCO2 < 24 mEq/L, risks for all CVEs and ischemic events were 17% and 15% higher, respectively (aHR for all CVEs of 0.83 [95% CI, 0.74-0.94] and aHR for ischemic CVEs of 0.85 [95% CI, 0.74-0.99]). Notably, tCO2 level < 20 mEq/L, compared to tCO2 level of 24.0 to 25.9 mEq/L, was independently associated with all-cause mortality (aHR, 1.43; 95% CI, 1.02-2.02). For every 1-mEq/L lower tCO2 level for those with tCO2 < 24 mEq/L, there was 17% higher risk for death (aHR, 0.83; 95% CI, 0.75-0.92). LIMITATIONS: Single-center observational study. CONCLUSIONS: Metabolic acidosis is an independent risk factor for ischemic CVEs after kidney transplantation. It is unknown whether correction of acidosis improves outcomes in these patients.
引用
- Djamali A, Singh T, Melamed ML, et al. Metabolic Acidosis 1 Year Following Kidney Transplantation and Subsequent Cardiovascular Events and Mortality: An Observational Cohort Study. Am J Kidney Dis. 2019. PMID: 30704880. doi:10.1053/j.ajkd.2018.12.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。